Plus Therapeutics GAAP EPS of -$0.01 beats by $0.07, revenue of $1.39M misses by $0.44M

Published 2 months ago Neutral
Plus Therapeutics GAAP EPS of -$0.01 beats by $0.07, revenue of $1.39M misses by $0.44M
Auto
* Plus Therapeutics press release [https://seekingalpha.com/pr/20201980-plus-therapeutics-reports-second-quarter-financial-results-and-recent-business-highlights] (NASDAQ:PSTV [https://seekingalpha.com/symbol/PSTV]): Q2 GAAP EPS of -$0.01 beats by $0.07.
* Revenue of $1.39M (+9.4% Y/Y) misses by $0.44M.

MORE ON PLUS THERAPEUTICS

* Plus Therapeutics announces $1.6 million advance payment from CPRIT [https://seekingalpha.com/news/4470498-plus-therapeutics-announces-16-million-advance-payment-from-cprit]
* Plus Therapeutics drops 5%, files prospectus for 17M share secondary offering [https://seekingalpha.com/news/4459309-plus-therapeutics-drops-5-files-prospectus-for-17m-share-secondary-offering]
* Seeking Alpha’s Quant Rating on Plus Therapeutics [https://seekingalpha.com/symbol/PSTV/ratings/quant-ratings]
* Historical earnings data for Plus Therapeutics [https://seekingalpha.com/symbol/PSTV/earnings]
* Financial information for Plus Therapeutics [https://seekingalpha.com/symbol/PSTV/income-statement]